SAN DIEGO, Calif., October 24, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced the...

Read more

San Diego, Calif., Oct. 17, 2016 — SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced that the company...

Read more

SAN DIEGO, February 9, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment...

Read more

Capital To Further Expand Commercial Operations And Broaden Product Portfolio SAN DIEGO, February 5, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based...

Read more

SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) — SENTÉ a specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycosaminoglycans, today announced the appointment of Michael Brower to...

Read more

Experienced Biopharmaceutical Industry Executive Adds to the Depth of the Company’s Board SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products...

Read more

Capital to Fund Expanded Commercial Operations and Broaden Product Portfolio SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on...

Read more

SAN DIEGO, Jul 11, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today the appointment of Michael York as...

Read more

Biotechnology Veteran Brings Deep Industry Expertise SAN DIEGO, May 24, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today that...

Read more

Funding to Support Commercial Operations and Additional Line Extensions to Senté’s Portfolio of Differentiated Skincare Products Based on Glycoproteins SAN DIEGO, May 14, 2013 (GLOBE NEWSWIRE) — Senté, Inc., a privately held cosmeceutical company engaged...

Read more